Cargando…

Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study

Background. Biologic agents targeting tumor necrosis factor alpha are effective in the management of ulcerative colitis (UC), but their use is often postponed until after failure of other treatment modalities. Objectives. We aim to determine if earlier treatment with infliximab or adalimumab alters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Christopher, Beilman, Candace L., Huang, Vivian W., Fedorak, Darryl K., Wong, Karen, Kroeker, Karen I., Dieleman, Levinus A., Halloran, Brendan P., Fedorak, Richard N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958475/ https://www.ncbi.nlm.nih.gov/pubmed/27478817 http://dx.doi.org/10.1155/2016/2079582

Ejemplares similares

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
por: Beilman, Candace L., et al.
Publicado: (2016)

Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
por: Lytvyak, Ellina, et al.
Publicado: (2020)

Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study
por: Keshteli, Ammar Hassanzadeh, et al.
Publicado: (2017)

Pregnancy-Related Beliefs and Concerns of Inflammatory Bowel Disease Patients Modified After Accessing e-Health Portal
por: Sutton, Reed T, et al.
Publicado: (2019)

Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education
por: Huang, Vivian Wai-Mei, et al.
Publicado: (2016)

Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission
por: Keshteli, Ammar Hassanzadeh, et al.
Publicado: (2022)

Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature
por: Verma, Sanam, et al.
Publicado: (2013)

Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn’s disease
por: Laffin, Michael R., et al.
Publicado: (2018)

Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions
por: Keshteli, Ammar Hassanzadeh, et al.
Publicado: (2019)

Increased Epithelial Gaps in the Small Intestine Are Predictive of Hospitalization and Surgery in Patients With Inflammatory Bowel Disease
por: Turcotte, Jean-Francois, et al.
Publicado: (2012)

A204 COST-EFFECTIVENESS OF THERAPIES AFTER FAILURE OF CONVENTIONAL THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS IN THE CANADIAN HEALTHCARE SYSTEM
por: Hagerman, C, et al.
Publicado: (2023)

A57 ULCERATIVE COLITIS DISEASE ACTIVITY IS DOMINATED BY INNATE IMMUNITY AND FEATURES OF TISSUE REMODELING
por: Madill-Thomsen, K, et al.
Publicado: (2022)

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study
por: Shim, Hang Hock, et al.
Publicado: (2018)

A160 MOLECULAR ANALYSIS OF THE INJURY-REPAIR RESPONSE IN ULCERATIVE COLITIS REVEALS HETEROGENEITY IN DISEASE ACTIVIT
por: Madill-Thomsen, K, et al.
Publicado: (2022)

Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA
por: Hotte, Naomi S. C., et al.
Publicado: (2012)

Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis
por: Perry, Troy, et al.
Publicado: (2017)

A146 THE EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN PATIENTS WITH ULCERATIVE COLITIS
por: Albino, L, et al.
Publicado: (2022)

An overview of clinical decision support systems: benefits, risks, and strategies for success
por: Sutton, Reed T., et al.
Publicado: (2020)

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
por: Rutgeerts, Paul J, et al.
Publicado: (2013)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFα, improves health-related quality of life in patients with moderate to severe Crohn’s disease
por: Rutgeerts, Paul, et al.
Publicado: (2007)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Polysomnography shows sleep fragmentation in patients with inactive inflammatory bowel disease
por: Beilman, Candace, et al.
Publicado: (2020)

Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis
por: Kruis, Wolfgang, et al.
Publicado: (2023)

A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice
por: Laffin, Michael, et al.
Publicado: (2019)

Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis
por: Zheng, Kai, et al.
Publicado: (2015)

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
por: Caron, Bénédicte, et al.
Publicado: (2022)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
por: Tindall, William N., et al.
Publicado: (2007)

Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
por: Awadhi, Sameer Al, et al.
Publicado: (2023)

Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey
por: Hébuterne, Xavier, et al.
Publicado: (2023)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
por: Caron, Bénédicte, et al.
Publicado: (2023)

A Mediterranean Diet Pattern Improves Intestinal Inflammation Concomitant with Reshaping of the Bacteriome in Ulcerative Colitis: A Randomised Controlled Trial
por: Haskey, Natasha, et al.
Publicado: (2023)

Dietary adherence to the Mediterranean diet pattern in a randomized clinical trial of patients with quiescent ulcerative colitis
por: Haskey, Natasha, et al.
Publicado: (2022)

Ulcerative Colitis and Crohn's Disease: Similarities and Distinctions
por: Sawyerr, Af M, et al.
Publicado: (1994)

Elevated IL-6 and IL-22 in Early Pregnancy Are Associated with Worse Disease Course in Women with Inflammatory Bowel Disease
por: Wu, Richard Y., et al.
Publicado: (2022)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iat74hja4ea1h2cjdvi1ssebpp